SCIENTURE HOLDINGS, INC. Cost of Revenue
SCIENTURE HOLDINGS, INC. (SCNX) reported Cost of Revenue of $7.86 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. cost of revenue for the quarter ending 2026-06-30 was $7.86K.
- SCIENTURE HOLDINGS, INC. cost of revenue for the quarter ending 2026-03-31 was $2.48K, a 74.18% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of revenue for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of revenue for the quarter ending 2025-03-31 was $9.59K.
- SCIENTURE HOLDINGS, INC. cost of revenue for fiscal 2025 was $100.13K, a 23.36% decline from fiscal 2024.
- SCIENTURE HOLDINGS, INC. cost of revenue for fiscal 2024 was $130.64K, a 90.06% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. cost of revenue for fiscal 2023 was $1.31M, a 72.21% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. cost of revenue for fiscal 2022 was $4.73M, a 8.02% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.86K 10-Q · filed 2026-08-13 | $10.34K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | $2.48K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | $100.13K 10-K · filed 2026-03-30 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $9.59K 10-Q · filed 2026-08-13 | $59.84K derived: sum of 3 quarters · filed 2026-08-13 | $120.82K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $9.59K 10-Q · filed 2026-05-15 | $59.84K derived: sum of 2 quarters · filed 2026-05-15 | $120.82K derived: sum of 3 quarters · filed 2026-05-15 | $140.22K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $50.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $111.24K derived: sum of 2 quarters · filed 2026-03-30 | $130.64K derived: sum of 3 quarters · filed 2026-03-30 | $130.64K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $60.98K 10-Q · filed 2024-11-06 | $80.38K derived: sum of 2 quarters · filed 2024-11-06 | $80.38K 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $19.40K 10-Q · filed 2024-08-09 | $19.40K 10-Q · filed 2024-08-09 | ||||
| 2023-12-31 | $242.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $595.32K derived: sum of 2 quarters · filed 2025-03-26 | $1.20M derived: sum of 3 quarters · filed 2025-03-26 | $1.31M 10-K · filed 2025-03-26 | $5.67M 10-K · filed 2024-04-22 | |
| 2023-09-30 | $352.69K 10-Q · filed 2024-11-06 | $959.04K derived: sum of 2 quarters · filed 2024-11-06 | $1.07M 10-Q · filed 2024-11-06 | $1.07M 10-Q · filed 2024-01-16 | $2.39M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $606.35K 10-Q · filed 2024-08-09 | $1.30M 10-Q · filed 2024-08-09 | $2.04M derived: sum of 3 quarters · filed 2024-08-09 | $2.02M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $690.67K 10-Q · filed 2024-06-26 | $1.43M derived: sum of 2 quarters · filed 2024-06-26 | $1.41M derived: sum of 3 quarters · filed 2024-06-26 | $3.52M derived: sum of 4 quarters · filed 2024-06-26 | ||
| 2022-12-31 | $739.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $718.51K derived: sum of 2 quarters · filed 2024-04-22 | $2.83M derived: sum of 3 quarters · filed 2024-04-22 | $4.73M 10-K · filed 2024-04-22 | $6.00M 10-K · filed 2023-03-27 | |
| 2022-09-30 | -$21.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | $2.09M derived: sum of 2 quarters · filed 2024-01-16 | $3.99M 10-Q · filed 2024-01-16 | $5.01M 10-Q · filed 2022-11-07 | $5.14M derived: sum of 4 quarters · filed 2024-01-16 | |
| 2022-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $4.01M 10-Q · filed 2023-08-18 | $5.16M derived: sum of 3 quarters · filed 2023-08-18 | $6.43M derived: sum of 4 quarters · filed 2023-08-18 | ||
| 2022-03-31 | $1.90M 10-Q · filed 2023-05-15 | $3.05M derived: sum of 2 quarters · filed 2023-05-15 | $4.32M derived: sum of 3 quarters · filed 2023-05-15 | $5.38M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $2.42M derived: sum of 2 quarters · filed 2023-03-27 | $3.47M derived: sum of 3 quarters · filed 2023-03-27 | $5.14M 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.33M derived: sum of 2 quarters · filed 2022-11-07 | $4.00M 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-25 | $2.73M 10-Q · filed 2022-07-25 | ||||
| 2021-03-31 | $1.67M 10-Q · filed 2022-05-09 | |||||
| 2018-09-30 | $2.35K 10-Q · filed 2018-10-26 | $2.35K 10-Q · filed 2018-10-26 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-10-26 | $0.00 derived: sum of 2 quarters · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $770.00 derived: sum of 2 quarters · filed 2017-11-07 | $16.36K 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $770.00 10-Q · filed 2017-08-04 | $16.36K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |